If you simply compare the average development times of pharmaceuticals, biotech and medical devices, you will see that medical devices demonstrate the shortest time from conception to market (or rejection). Devices, by virtue of providing, in many cases, a simple mechanical function — flatten atherosclerotic plaque against the lumen (angioplasty), keep it there (stents), close [...]
Below is the coverage in the April 2008 issue of MedMarkets.
Ablation: An Energized Market
Demand for Hip and Knee Implants Expected to Increase
MedMarket Outlook: Beyond Technology Innovation: Current and Future Market Forces and Trends
Early Stage Companies: Evalve, ES Vascular, Cardiorobotics, TriVascular
Early Stage Company Financings: Alure Medical, Arbel Medical, Breathe Technologies, CoAxia, IDev Technologies, IlluminOss [...]
The revenues to be had from the clinical management of obesity, whether derived from pharmaceutical or device sales, are forecast to see double-digit growth through 2015. Although revenues have been dampened by the FDA’s negative reaction to Sanofi-Aventis’ application for rimonabant, there are other drug compounds in late stages of testing which may prove to [...]
We have just updated our “High Growth Medical Technologies” white paper, as we expect to continually do in the immediate future, since the areas with growth keep changing, and new areas keep appearing.
As all white papers should be, it’s free. Here’s the link so you can download it.
bookmark to
New medical technologies represented in companies added (March 2008) to the Medtech Startups Database and/or added to the March 2008 issue of MedMarkets:
Cardiac rhythm monitor.
Diagnosis of pediatric vesicoureteral reflux.
Developing atherectomy for peripheral vascular disease.
Systems to facilitate arthroscopic surgery.
Bioimplants for surgery.
Instrumentation for use in laparoscopic surgery.
Interbody spacers for spine surgery.
Electrosurgical instrumentation.
Drug startup
Pediatric therapeutics
Non-surgical treatment of obesity [...]
